It was approved in the UK in late 2023 and became available through specialist NHS weight management services in 2024
Choose what suits your routine best
Study outcomes In this large, population-based retrospective cohort study, our primary outcome was to assess the incidence or new-onset of major adverse cardiovascular events categorized as HF, composite cardiovascular events 23,24 , as well as clinically significant portal hypertension events 25
What is Retatrutide Peptide and How Does It Work
For instance, in a study of early worsening of DR after intensive insulin treatment, pancreas transplant, or bariatric surgery, 2 10% to 20% of patients had worsening of DR within three to six monthswith twice that many for patients who already had advanced DR at baseline